# Stromal Vascular Fraction (SVF) Therapy in Patients With Acute Spontaneous Intracerebral Hemorrhage (SICH).

> **NCT05232903** · PHASE1 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Spontaneous Intracerebral Hemorrhage

## Interventions

- **BIOLOGICAL:** SVF therapy group

## Key facts

- **NCT ID:** NCT05232903
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232903, "Stromal Vascular Fraction (SVF) Therapy in Patients With Acute Spontaneous Intracerebral Hemorrhage (SICH).". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05232903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*